Literature DB >> 26423532

Familial inflammatory bowel diseases in Northwest Greece.

Konstantinos H Katsanos1, Anna Giga1, Dimitrios K Christodoulou1, Epameinondas V Tsianos1.   

Abstract

Entities:  

Year:  2015        PMID: 26423532      PMCID: PMC4585407     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
We read with interest the articles by Ben-Horin et al [1] and Arias-Loste [2]. Indeed, inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), have been recognized for many years now to include a hereditary component. Familial occurrence in IBD is probably expected to be less frequent in Greece compared to Northern Europe and America [3]. According to retrospective studies, first-degree familial clustering of IBD in the Mediterranean area, including Greece, seems to not exceed 7% in adult [4,5] and 8.5% in pediatric cases [6]. We herein present the results of our study aiming to record all IBD cases with familial clustering in our area. Medical records of all IBD patients followed up at the Division of Gastroenterology at the Ioannina University Hospital and the Northwest Greece IBD Study Group, were retrospectively assessed and studied concerning the existence of all other family members with a firm diagnosis of IBD. A total of 557 patients with IBD were analyzed and 32 families with at least 2 IBD affected members (first- and second-degree relatives) were recorded. Among these 557 patients, 331 were male (59.4%) and 226 female (40.6%). Among male patients, 211 (63.7%) had UC, 75 (22.7%) had CD and 45 (13.6%) had undetermined colitis (IC). Among females, 145 (64.2%) had UC, 64 (28.3%) CD, and 17 (7.5%) IC. Thirty-two families with at least 2 IBD affected members (first- and second-degree relatives) were recorded, totaling 69 patients. Among these families, there were 26 (81.3%) with concordant diagnoses and 6 (18.7%) with disconcordant diagnoses (Table 1).
Table 1

Intrafamilial inflammatory bowel diseases (IBD) in Northwest Greece

Intrafamilial inflammatory bowel diseases (IBD) in Northwest Greece This study showed that any type of confirmed inheritance (first- or second-degree relatives) seems to play a role in IBD familial clustering with a crude rate of 12.4% of our IBD cohort. In this IBD cohort, there was a male predominance and a clear increase in familial UC predisposition compared to CD. The time frame of sequential diagnoses, like a domino effect, in many of these families we described herein, points towards an environmental factor to which all siblings, and probably also their parents, were exposed during the same period of time. Of interest, we also recorded one familial IBD case of immigrants in our area [7]. Familial IBD in immigrants have rarely been reported and seem to be of exceptional interest towards a better understanding of disease etiopathogenesis and potential risk factors related also to immigration [8]. Immigrant family cases illustrate potential bias in genetically based studies of CD that rely solely on phenotypic expression. Indeed, it seems that many people might have IBD in their genetic background but either they never express it phenotypically or they express it only under special environmental circumstances such as in the immigration land. It would be of exceptional interest if any other family members could be investigated for any evidence of silent CD at the time of diagnosis of the disease in their siblings [9]. It can be anticipated that systematic familial screening for silent IBD cases following the first family member diagnosis may explain some of the mystery of the familial IBD aggregation.
  9 in total

1.  Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases.

Authors:  J K Triantafillidis; A Emmanouilidis; O Manousos; D Nicolakis; M Kogevinas
Journal:  Digestion       Date:  2000       Impact factor: 3.216

2.  Continuing low incidence of Crohn's disease in Northwest Greece.

Authors:  E V Tsianos; K H Katsanos; D Christodoulou; I Dimoliatis; A Kogevinas; R F Logan
Journal:  Dig Liver Dis       Date:  2003-02       Impact factor: 4.088

3.  Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom.

Authors:  Eftychia Tsironi; Roger M Feakins; Chris S J Probert; Chris S J Roberts; David S Rampton; D Phil
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

4.  Familial aggregation of inflammatory bowel disease in a Mediterranean area.

Authors:  C Cipolla; A Magliocco; L Oliva; M Cottone
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

Review 5.  A family report of Crohn's disease in three children immigrating from Albania to Greece and review of the literature.

Authors:  Konstantinos H Katsanos; Vasileios Karetsos; Epameinondas V Tsianos
Journal:  J Crohns Colitis       Date:  2010-07-03       Impact factor: 9.071

6.  Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease.

Authors:  Subra Kugathasan; Anthony Loizides; Umesh Babusukumar; Erin McGuire; Tao Wang; Pleasant Hooper; Justin Nebel; Galina Kofman; Richard Noel; Ulrich Broeckel; Vasundhara Tolia
Journal:  Inflamm Bowel Dis       Date:  2005-07       Impact factor: 5.325

7.  Inflammatory bowel disease in children: the role of a positive family history.

Authors:  Eleftheria S Roma; Joanna Panayiotou; Joanna Pachoula; Catherin Constantinidou; Alexandros Polyzos; Aglaia Zellos; Evagelia Lagona; Gerassimos J Mantzaris; Vassiliki P Syriopoulou
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 2.566

8.  Familial ulcerative colitis in Israeli Jews: its prevalence and clinical severity compared to sporadic disease.

Authors:  Shomron Ben-Horin; Shira Tamir; Uri Kopylov; Lion Katz; Moshe Nadler; Alon Lang; Benjamin Avidan; Yehuda Chowers
Journal:  Ann Gastroenterol       Date:  2011

Review 9.  Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Authors:  Maria Teresa Arias-Loste; Beatriz Castro; Montserrat Rivero; Javier Crespo
Journal:  Ann Gastroenterol       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.